Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to HB 800.
Introduced
Jan 13, 2026
Last Action
Mar 10, 2026
Session
VA 2026
Sponsors
1 primary · 0 co
Enrolled Bill communicated to Governor on March 10, 2026
Governor's Action Deadline 11:59 p.m., April 13, 2026
Enrolled
Signed by President
Signed by Speaker
Fiscal Impact Statement from Department of Planning and Budget (SB404)
Bill text as passed Senate and House (SB404ER)
Read third time
Passed House (97-Y 0-N 0-A)
Read second time
Reported from Appropriations (22-Y 0-N)
Assigned HAPP sub: Commerce Agriculture & Natural Resources
Referred to Committee on Appropriations
Placed on Calendar
Read first time
Read third time and passed Senate (38-Y 0-N 0-A)
Engrossed by Senate (Voice Vote)
Read second time
Rules suspended
Passed by for the day
Passed by for the day Block Vote (Voice Vote)
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
Reported from Finance and Appropriations (14-Y 0-N)
Fiscal Impact Statement from Department of Planning and Budget (SB404)
Referred to Committee on Finance and Appropriations
Prefiled and ordered printed; Offered 01-14-2026 26102909D
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Governor's Action Deadline 11:59 p.m., April 13, 2026
L. Louise Lucas